These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15476583)

  • 21. Estrogen receptor subtype-specific effects on markers of bone homeostasis.
    Hertrampf T; Schleipen B; Velders M; Laudenbach U; Fritzemeier KH; Diel P
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):104-8. PubMed ID: 18433985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
    Vargas SJ; Naprta A; Lee SK; Kalinowski J; Kawaguchi H; Pilbeam CC; Raisz LG; Lorenzo JA
    J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
    Han X; Xu Y; Wang J; Pei X; Yang R; Li N; Li Y
    Bone; 2009 May; 44(5):942-7. PubMed ID: 19124090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docosahexaenoic acid and 17 beta-estradiol co-treatment is more effective than 17 beta-estradiol alone in maintaining bone post-ovariectomy.
    Poulsen RC; Moughan PJ; Kruger MC
    Exp Biol Med (Maywood); 2008 May; 233(5):592-602. PubMed ID: 18375826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment.
    Christoffel J; Rimoldi G; Wuttke W
    J Endocrinol; 2006 Mar; 188(3):397-405. PubMed ID: 16522720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
    Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
    J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of hysterectomy on bone in intact rats, ovariectomized rats, and ovariectomized rats treated with estrogen.
    Goulding A; Gold E; Lewis-Barned NJ
    J Bone Miner Res; 1996 Jul; 11(7):977-83. PubMed ID: 8797119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats.
    Shen V; Birchman R; Xu R; Lindsay R; Dempster DW
    Bone; 1995 Jan; 16(1):149-56. PubMed ID: 7742074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a prospective anti-osteoporosis effect of black tea (Camellia Sinensis) extract in a bilaterally ovariectomized rat model.
    Das AS; Mukherjee M; Mitra C
    Asia Pac J Clin Nutr; 2004; 13(2):210-6. PubMed ID: 15228990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
    Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
    J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
    Coelingh Bennink HJ; Heegaard AM; Visser M; Holinka CF; Christiansen C
    Climacteric; 2008; 11 Suppl 1():2-14. PubMed ID: 18464016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency-dependent effect of nitric oxide donor nitroglycerin on bone.
    Wimalawansa S; Chapa T; Fang L; Yallampalli C; Simmons D; Wimalawansa S
    J Bone Miner Res; 2000 Jun; 15(6):1119-25. PubMed ID: 10841180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.
    Naves-Díaz M; Carrillo-López N; Rodríguez-Rodríguez A; Braga S; Fernández-Coto T; Lopez-Novoa JM; López-Hernández F; Cannata-Andía JB
    Menopause; 2010 Jul; 17(4):766-71. PubMed ID: 20386345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH.
    Rouach V; Katzburg S; Koch Y; Stern N; Somjen D
    J Cell Biochem; 2011 Jan; 112(1):128-37. PubMed ID: 21053364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
    Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol.
    Li XX; Hara I; Matsumiya T
    Biol Pharm Bull; 2002 Jun; 25(6):738-42. PubMed ID: 12081139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.